Ignite Creation Date:
2024-05-06 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04704323
Status:
RECRUITING
Last Update Posted:
2024-02-15
First Post:
2020-12-21
Brief Title:
CAP-100 for Subjects With RelapsedRefractory Chronic Lymphocytic Leukemia
Sponsor:
Catapult Therapeutics
Organization:
Catapult Therapeutics
Organization Data
Organization:
Catapult Therapeutics
Class:
INDUSTRY
Study ID:
CAP-100-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Catapult Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None